Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Will Leqembi’s primary benefit—a slight slowing of decline in cognition and functioning—make a difference to patients and family members...
The first studies, launched on July 31, will focus on viral persistence and cognitive dysfunction.
Findings from NIH study offer insight into biological mechanisms, pointing to possible treatments.
Researchers encourage additional studies to determine why Black and Latino people experience long COVID symptoms more than white people.
Findings from small NIH study could provide insight into long-term neurological symptoms of COVID-19.
The higher rate of post-COVID symptoms in older adults is likely due to a higher incidence of chronic disease and physical vulnerability.
Novel therapies, improved technologies and a better understanding of the immune system could yield broad dividends.
Over-stimulated immune system may be impetus to cognitive symptoms, USCF-led study shows.
The World Trade Center dust plume exposed thousands to dangerous pollutants. Now the health consequences are clear.
Excess weight, which is often linked to metabolic abnormalities, can contribute to a wide variety of health problems.
Sudden cognitive dysfunction is a common concern for seniors who’ve survived a serious bout of COVID-19.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.